Evidence map›Paper›PMID 39408596›Full record

ArticleInternational journal of molecular sciences2024

Three-Dimensional-Bioprinted Non-Small Cell Lung Cancer Models in a Mouse Phantom for Radiotherapy Research.

Yikun Mei, Elena Lakotsenina, Marie Wegner, Timon Hehne, Dieter Krause, Dani Hakimeh, Dongwei Wu, Elisabeth Schültke, Franziska Hausmann, Jens Kurreck and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yikun MeiDepartment of Applied Biochemistry, Institute of Biotechnology, Technische Universität Berlin, 10623 Berlin, Germany.ORCID 0000-0003-1881-753X
Elena LakotseninaDepartment of Radiation Oncology, Charité University Medicine Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, 13353 Berlin, Germany.
Marie WegnerDepartment of Product Development and Mechanical Engineering Design, Hamburg University of Technology, 21073 Hamburg, Germany.ORCID 0000-0001-8616-859X
Timon HehneDepartment of Radiation Oncology, Charité University Medicine Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, 13353 Berlin, Germany.
Dieter KrauseDepartment of Product Development and Mechanical Engineering Design, Hamburg University of Technology, 21073 Hamburg, Germany.ORCID 0000-0002-1253-1699
Dani HakimehDepartment of Applied Biochemistry, Institute of Biotechnology, Technische Universität Berlin, 10623 Berlin, Germany.ORCID 0000-0003-3368-0121
Dongwei WuDepartment of Applied Biochemistry, Institute of Biotechnology, Technische Universität Berlin, 10623 Berlin, Germany.ORCID 0000-0001-5446-7376
Elisabeth SchültkeDepartment of Radiooncology, Rostock University Medical Center, 18059 Rostock, Germany.ORCID 0000-0002-1273-0065
Franziska HausmannDepartment of Radiation Oncology, Charité University Medicine Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, 13353 Berlin, Germany.ORCID 0000-0002-2432-7716
Jens KurreckDepartment of Applied Biochemistry, Institute of Biotechnology, Technische Universität Berlin, 10623 Berlin, Germany.ORCID 0000-0002-1469-0052
Beatrice TolksdorfDepartment of Applied Biochemistry, Institute of Biotechnology, Technische Universität Berlin, 10623 Berlin, Germany.ORCID 0000-0002-1073-7503

Funding

Chinese Scholarship Council 201906780024Chinese Scholarship Council 202006230125Einstein Foundation Berlin EZ-2020-597-2
6 · The paper itself

Abstract

Lung cancer continues to have one of the highest morbidity and mortality rates of any cancer. Although radiochemotherapy, in combination with immunotherapy, has significantly improved overall survival, new treatment options are urgently needed. However, preclinical radiotherapy testing is often performed in animal models, which has several drawbacks, including species-specific differences and ethical concerns. To replace animal models, this study used a micro-extrusion bioprinting approach to generate a three-dimensional (3D) human lung cancer model consisting of lung tumor cells embedded in human primary lung fibroblasts for radiotherapy research. The models were placed in a mouse phantom, i.e., a 3D-printed mouse model made of materials that mimic the X-ray radiation attenuation rates found in mice. In radiotherapy experiments, the model demonstrated a selective cytotoxic effect of X-rays on tumor cells, consistent with findings in 2D cells. Furthermore, the analysis of metabolic activity, cell death, apoptosis, and DNA damage-induced γH2AX foci formation revealed different results in the 3D model inside the phantom compared to those observed in irradiated models without phantom and 2D cells. The proposed setup of the bioprinted 3D lung model inside the mouse phantom provides a physiologically relevant model system to study radiation effects.

Indexed as

BioprintingCarcinoma, Non-Small-Cell LungLung NeoplasmsPrinting, Three-DimensionalAnimalsApoptosisCell Line, TumorDisease Models, AnimalDNA DamageHumansMicePhantoms, ImagingX-Rays3D bioprintinglung cancermodel systemmouse phantomradiation therapy

Identifiers

PMID39408596
PMCPMC11476964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.